The novel MEK inhibitor atebimetinib in combination with modified gemcitabine/nab-paclitaxel led to a 12-month overall ...

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...

Please provide your email address to receive an email when new articles are posted on . Adults with diabetes using SGLT2 inhibitors have lower risks for developing cancers than those who do not use ...